Psyence Biomedical Ltd. (PBM) Total Debt (2023 - 2025)
Psyence Biomedical (PBM) posted quarterly Total Debt of $298368.0 for Q3 2025, down 76.19% year-over-year from $1.3 million in Q3 2024, and up 49.11% quarter-over-quarter from $200096.0 in Q1 2025.
Psyence Biomedical Ltd. (PBM) Total Debt (2023 - 2025) Analysis & Trends
Psyence Biomedical's Total Debt history runs 3 years deep, the most recent figure standing at $298368.0 for Q3 2025.
- In Q3 2025, Total Debt fell 76.19% year-over-year to $298368.0; the TTM figure through Sep 2025 stood at $298368.0 (down 76.19% YoY), while the FY2025 annual figure was $200096.0, down 86.43% from the prior year.
- Total Debt for Q3 2025 stood at $298368.0, up from $200096.0 in the prior quarter.
- The five-year high for Total Debt was $1607.8 billion in Q3 2023, with the low at $200096.0 in Q1 2025.
- The 3-year median for Total Debt is $1.3 million (2024), against an average of $321.6 billion.
- The sharpest annual moves came in 2024 and 2025: Total Debt slumped 100.0% in 2024, then tumbled 76.19% in 2025.
- Psyence Biomedical's Total Debt stood at $1607.8 billion in 2023, then plunged by 100.0% to $1.3 million in 2024, then sank by 76.19% to $298368.0 in 2025.
- Business Quant data shows PBM's Total Debt at $298368.0 in Q3 2025, $200096.0 in Q1 2025, and $1.3 million in Q3 2024.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 298,368.00 |
| Mar 31, 2025 | 200,096.00 |
| Sep 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Sep 30, 2023 | 1,607.77 Bn |